±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1121  |  »Ø¸´: 9
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßzhaoyongqiangÔö¼Ó½ð±Ò 1.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


[×ÊÔ´] Reversed Phase Chromatography(ÍâÎÄÊé¼®)

ÏÂÔØµØÖ·http://www.namipan.com/d/Reverse ... 3e9f7057b6b0c7e0800

Contents
1. Introduction ..............................................................................................5
Theory of reversed phase chromatography ...............................................6
The matrix ................................................................................................9
The ligands ............................................................................................. 11
Resolution in reversed phase chromatography ........................................ 13
Resolution .............................................................................................. 13
Capacity factor ....................................................................................... 14
Efficiency ................................................................................................ 15
Selectivity ................................................................................................ 17
Binding capacity ..................................................................................... 18
Critical parameters in reversed phase chromatography........................... 19
Column length ...................................................................................19
Flow rate ............................................................................................19
Temperature ....................................................................................... 20
Mobile phase ..................................................................................... 20
Organic solvent .................................................................................. 20
Ion suppression .................................................................................. 21
Ion pairing agents .............................................................................. 22
Gradient elution ................................................................................. 23
Mode of use ............................................................................................24
Desalting ............................................................................................24
High resolution separations ............................................................... 25
Large scale preparative purification ................................................... 25
Stages in a purification scheme .......................................................... 26
Capture .............................................................................................. 26
Intermediate stages .............................................................................27
Polishing ............................................................................................27
2. Product Guide .........................................................................................29
SOURCE™ RPC ..................................................................................... 30
Product description ............................................................................ 30
High chemical stability ...................................................................... 32
Excellent flow/pressure characteristics ................................................ 34
High capacity ..................................................................................... 35
Availability ........................................................................................ 36
¦ÌRPC C2/C18 .........................................................................................37
Product description ............................................................................ 37
Chemical and physical stability .......................................................... 38
Flow/pressure characteristics ..............................................................38
Capacity ............................................................................................38
Availability ........................................................................................ 39
Sephasil™ Protein/Sephasil Peptide ......................................................... 39
Product description ............................................................................ 39
Chemical and physical stability .......................................................... 40
Flow/pressure characteristics ..............................................................40
Availability ........................................................................................ 40
3. Methods ................................................................................................. 41
Choice of separation medium .................................................................41
Unique requirements of the application .............................................. 41
Resolution .......................................................................................... 41
Scale of the purification ..................................................................... 42
Mobile phase conditions ....................................................................42
Throughput and scaleability ..............................................................42
Molecular weight of the sample components ......................................42
Hydrophobicity of the sample components ........................................ 43
Class of sample components ..............................................................43
Choice of mobile phase ........................................................................... 44
The organic solvent ............................................................................ 44
pH .....................................................................................................46
Ion pairing agents .............................................................................. 47
Sample preparation................................................................................. 49
Mobile phase preparation .......................................................................50
Storage of mobile phase ..................................................................... 50
Solvent disposal ................................................................................. 50
Detection ................................................................................................ 51
Ghosting ............................................................................................51
Mobile phase balancing ..................................................................... 51
Column conditioning .............................................................................. 52
Elution conditions ...................................................................................53
Column re-equilibration ......................................................................... 55
Column cleaning ..................................................................................... 55
Column storage ......................................................................................56
4. Applications............................................................................................57
Designing a biochemical purification ...................................................... 57
Naturally occurring peptides and proteins .............................................. 58
Purification of platelet-derived growth factor (PDGF) ........................ 59
Trace enrichment ............................................................................... 59
Purification of cholecystokinin-58 (CCK-58) from pig intestine ......... 60
Recombinant peptides and proteins ........................................................62
Process purification of inclusion bodies .............................................. 63
Purification of recombinant human epidermal growth factor ............. 63
Chemically synthesised peptides..............................................................65
Purification of a phosphorylated PDGF a-receptor derived peptide .... 65
Structural characterisation of a 165 kDa protein ............................... 66
Protein fragments from enzyme digests ................................................... 66
Protein characterisation at the micro-scale .........................................66
Protein identification by LC-MS ......................................................... 69
Chemically synthesised oligonucleotides ................................................. 70
5. Fault finding chart .................................................................................. 72
6. References ...............................................................................................81
7. Ordering information .............................................................................84

[ Last edited by zhaoyongqiang on 2008-3-17 at 12:07 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÔÂÁÁÍäÍä

½ð³æ (ÖøÃûдÊÖ)


½éÉÜһϱȽϺÃ
2Â¥2008-03-17 11:58:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dnp

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¼ûÊéÆÀÌû¡­¡­
3Â¥2008-03-17 11:59:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


¡¾ÆÀ¼Û¡¿  ¡ï¡ï¡ï¡ï¡ï (ÎåÐǼ¶,ÓÅÐãÍÆ¼ö)

¼ûÊéÆÀÌû¡­¡­
4Â¥2008-03-17 12:03:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

weifengnit

ľ³æ (ÕýʽдÊÖ)


Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£
5Â¥2008-03-17 13:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by ruyibaobei at 2008-3-17 12:34:
ºÃ¶«¶«

¼ûÊéÆÀÌû¡­¡­
7Â¥2008-03-18 15:35:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
8Â¥2008-03-19 14:50:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
9Â¥2008-04-10 11:46:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-03-17 15:01   »Ø¸´  
ÒýÓûØÌû:
Originally posted by weifengnit at 2008-3-17 13:48: Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£

Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zhaoyongqiang µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì¿¼ÑÐ +6 Õü¾ÈÆ¤ÌØÍÐÏÈÉú 2026-04-02 6/300 2026-04-02 22:47 by liveagain126
[¿¼ÑÐ] »¯¹¤µ÷¼Á303·Ö£¬¹ýËļ¶ +14 ÆÜÎà´ý·ç 2026-04-02 14/700 2026-04-02 21:58 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] ½»Í¨ÔËÊ俼ÊÔ264·ÖÇ󹤿Ƶ÷¼Á +4 jike777 2026-04-02 4/200 2026-04-02 21:53 by zllcz
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¹¤Òµ´óѧ£¬324·ÖÇóµ÷¼Á +7 Áã°Ë# 2026-03-28 7/350 2026-04-02 21:09 by 1104338198
[¿¼ÑÐ] 285Çóµ÷¼Á +14 AZMK 2026-04-02 14/700 2026-04-02 15:54 by ÉϾÅÌìÀ¿Ô£¨ºÃÔ
[¿¼ÑÐ] 329Çóµ÷¼Á +8 miaodesi 2026-04-02 10/500 2026-04-02 10:24 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 09:52 by yulian1987
[¿¼ÑÐ] ½­ËտƼ¼´óѧÕвÄÁÏÑо¿Éú +4 Su032713. 2026-04-01 5/250 2026-04-01 22:03 by cccchenso
[¿¼ÑÐ] 086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á +7 °¢Ò̸´¹Å²»¹ý 2026-03-27 7/350 2026-04-01 16:14 by yanflower7133
[¿¼ÑÐ] 311Çóµ÷¼Á +10 ÀîÜÆÐÂ1 2026-03-31 10/500 2026-04-01 14:38 by chenqifeng666
[¿¼ÑÐ] ÉúÎïѧ296Çóµ÷¼Á +10 ÌÀÔ²°ü 2026-03-29 14/700 2026-04-01 10:44 by Çóµ÷¼Ázz
[¿¼ÑÐ] 0710ÉúÎïѧÇóµ÷¼Á£¡ +6 ÐðÊöÎÄ 2026-03-31 6/300 2026-04-01 09:39 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +5 Ë«ÂíβƦÀϰå2 2026-03-31 5/250 2026-04-01 09:04 by oooqiao
[¿¼ÑÐ] 352·Ö-085602-Ò»Ö¾Ô¸985 +6 º£Äɰٴ¨Ly 2026-03-29 6/300 2026-03-31 21:06 by yuq
[¿¼ÑÐ] 313Çóµ÷¼Á +6 Âô¸ö¹Ø×Ó°É 2026-03-31 6/300 2026-03-31 10:58 by Jaylen.
[¿¼ÑÐ] 276Çóµ÷¼Á +3 ÕԾûª 2026-03-29 3/150 2026-03-31 10:06 by cal0306
[¿¼ÑÐ] 283Çóµ÷¼Á£¨080500£© +14 A child 2026-03-27 14/700 2026-03-30 12:06 by ̽123
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
[¿¼ÑÐ] ±¾¿ÆÐÂÄÜÔ´¿ÆÑ§Ó빤³Ì£¬Ò»Ö¾Ô¸»ªÀíÄܶ¯285Çóµ÷¼Á +3 AZMK 2026-03-27 5/250 2026-03-28 16:19 by xxxsssccc
[¿¼ÑÐ] 285Çóµ÷¼Á +4 AZMK 2026-03-27 7/350 2026-03-27 20:59 by AZMK
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û